|
Originally published In Press as doi:10.1074/jbc.M200009200 on April 16, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24490-24498, July 5, 2002
Pseudomonas aeruginosa Aspartate
Transcarbamoylase
CHARACTERIZATION OF ITS CATALYTIC AND REGULATORY PROPERTIES*
John F.
Vickrey ,
Guy
Hervé§, and
David R.
Evans ¶
From the Department of Biochemistry and Molecular
Biology, Wayne State University School of Medicine,
Detroit, Michiagan 48201 and the § Laboratoire de
Biochimie des Signaux Régulateurs Cellulaires et
Moléculaires, UMR CNRS 7631, Université Pierre et Marie
Curie, 96 Bd. Raspail, 75006 Paris, France
Received for publication, January 2, 2002, and in revised form, March 13, 2002
 |
ABSTRACT |
Aspartate transcarbamoylase from Pseudomonadaceae
is a class A enzyme consisting of six copies of a 36-kDa catalytic
chain and six copies of a 45-kDa polypeptide of unknown function. The 45-kDa polypeptide is homologous to dihydroorotase but lacks catalytic activity. Pseudomonas aeruginosa aspartate
transcarbamoylase was overexpressed in Escherichia
coli. The homogeneous His-tagged protein isolated in high
yield, 30 mg/liter of culture, by affinity chromatography and
crystallized. Attempts to dissociate the catalytic and
pseudo-dihydroorotase (pDHO) subunits or to express catalytic subunits
only were unsuccessful suggesting that the pDHO subunits are required
for the proper folding and assembly of the complex. As reported
previously, the enzyme was inhibited by micromolar concentrations of
all nucleotide triphosphates. In the absence of effectors, the
aspartate saturation curves were hyperbolic but became strongly
sigmoidal in the presence of low concentrations of nucleotide
triphosphates. The inhibition was unusual in that only free ATP, not
MgATP, inhibits the enzyme. Moreover, kinetic and binding studies with
a fluorescent ATP analog suggested that ATP induces a conformational
change that interferes with the binding of carbamoyl phosphate but has
little effect once carbamoyl phosphate is bound. The peculiar
allosteric properties suggest that the enzyme may be a potential target
for novel chemotherapeutic agents designed to combat
Pseudomonas infection.
 |
INTRODUCTION |
Pseudomonadaceae is a family of eubacteria with a wide ecological
distribution that is pathogenic in animals (1, 2). Pseudomonas aeruginosa, the principle cause of
morbidity and mortality in immunocompromised patients and burn victims
(3-5), is an obligate pathogen. In cystic fibrosis, P. aeruginosa infection is the usual cause of death. In the design of
therapeutic strategies, comparatively little attention has focused on
the physiology of the organism itself, despite the unusual metabolism
exhibited by Pseudomonadaceae such as uracil catabolism (6), the lack
of gene repression (7, 8), and the ability to use arginine as the sole
source of carbon, nitrogen, and energy (9, 10).
In other organisms, studies of de novo pyrimidine
biosynthesis and salvage are actively pursued because of the
relationship of these pathways to growth, development, and
chemotherapy. Aspartate transcarbamoylase
(ATCase,1 EC 2.1.3.2)
catalyzes the formation of carbamoyl aspartate from carbamoyl phosphate
and aspartate (11) in the de novo biosynthetic pathway. The
structure and function of the enzyme from Escherichia coli
has been extensively studied and has become the prototype of allosteric
enzymes. However, ATCases are highly polymorphic differing both in
structure and mode of regulation. Jones and co-workers (12) identified
three distinct classes of bacterial aspartate transcarbamoylase.
E. coli ATCase, designated a class B enzyme, consists of six
copies of two types of polypeptide chains, catalytic and regulatory. The 34-kDa catalytic chains associate to form catalytically active but
unregulated trimers. The 17-kDa regulatory chains form dimeric subunits
that bind the allosteric effectors CTP, ATP, and UTP but have no
activity. Crystallographic studies (13-16) have shown that the
holoenzyme is a 32 dodecamer consisting of two catalytic subunits and three regulatory subunits. The allosteric effectors bind
to a common site on each regulatory chain and transmit allosteric signals to the active site located 60 Å away on the catalytic subunit.
In addition to E. coli, class B ATCases are found in other
members of the family Enterobacteriaceae such as Salmonella typhimurium, Erwinia herbicola, Serratia
marcescens (17), and in some hyperthermophilic archeae such as
Pyrococcus abyssi (18). The class B ATCases differ in
sensitivity to allosteric effectors but have the same structural organization.
The class C enzymes are much smaller, 100 kDa, and lack separate
regulatory subunits. Barbson and Switzer (19) characterized the first
class C ATCase from Bacillus subtilis. The enzyme was shown
to be an unregulated trimer consisting of three 34-kDa catalytic chains. When the enzyme was cloned and sequenced, it was found (20) to
be homologous to the E. coli ATCase catalytic chain, and
subsequent x-ray studies (21) showed that it has a very similar
tertiary structure.
The class A ATCases are the largest and least well understood. Early
studies of Pseudomonas fluorescens ATCase (22) suggested that the molecule was dimeric; however, it was subsequently shown (23,
24) to be a dodecamer consisting of six copies of a 36-kDa catalytic
chain and 45-kDa polypeptide of unknown function. When O'Donovan and
associates (25, 45) cloned and sequenced the genes encoding the
enzyme from Pseudomonas putida and P. aeruginosa, the surprising discovery was that, although the 36-kDa chains were
clearly homologous to the catalytic chains of other well characterized
ATCases, the sequence of the 45-kDa polypeptide closely resembled
dihydroorotase, the enzyme that catalyzes the subsequent step in the
de novo pyrimidine biosynthetic pathway. However, the enzyme
complex lacks dihydroorotase activity, so the 45-kDa polypeptide has
been designated a pseudo-DHOase, analogous to the homologous inactive
domain found (26) in the yeast multifunctional protein encoded by the
ura2 locus.
The regulation of the Pseudomonas enzyme is also unusual. In
E. coli the flux of metabolites through the de
novo pyrimidine biosynthesis is controlled by the allosteric
regulation of ATCase. ATP activates the enzyme whereas CTP and UTP
function as feedback inhibitors. The reciprocal regulation of the
enzyme by these allosteric effectors is thought to prevent the
accumulation of pyrimidines and to maintain a balance in the
intracellular pools of purines and pyrimidines. In contrast,
Pseudomonas ATCase (22, 23) is inhibited by low
concentrations of all of the nucleotide triphosphates. Although there
is precedent in that the enzymes from several other bacterial species
are inhibited by a broad spectrum of pyrimidines and purines (27), the
rationale for this type of allosteric control of de
novo pyrimidine biosynthesis has been elusive.
Mechanistic and structural studies of Pseudomonadaceae aspartate
transcarbamoylase have been hampered by the difficulty in isolating
sufficient quantities of the protein and by its intrinsic instability.
This report describes the overexpression, purification, and
characterization of P. aeruginosa ATCase. The
extreme sensitivity of the purified recombinant protein to nucleotide
triphosphates was confirmed, but the regulation was found to be unusual
in several respects.
 |
EXPERIMENTAL PROCEDURES |
Strains and Plasmids--
The plasmid, pA10, that encodes both
the subunits of P. aeruginosa ATCase was obtained (45;
GenBankTM accession number L19649) by inserting a 3.5-kb
XhoI fragment of the cosmid 011125 that complemented
ATCase-deficient E. coli strains into the SalI
site of pUC18. The expression vector pRSETC was purchased from
Invitrogen. Host E. coli cells were either EK1104
(F , ara, thi,
pro-lac, pyrB, pyrF±,
rpsL) (28), BL21 (DE3) (F dcm
ompT hsdS(rB-mB-)
gal (DE3)), or DH5 (F ( 80d
lacZ M15) d(lacZYA-argF)U169
endA1 recA1 hsdR17(rK-mK+)deoR thi-1 supE44 gyrA96 relA1  ). Routine
genetic manipulations were carried out using the strain DH5a.
Protein and DNA Methods--
Restriction digests, ligations, and
other DNA methods were carried out using standard protocols (29).
Protein concentration was determined by the Lowry method (30) using
bovine serum albumin as the standard. SDS-gel electrophoresis was
carried out on 12% polyacrylamide gels (31). In some instances, 6%
non-denaturing polyacrylamide gels were run, and the ATCase activity of
the bands in the gel was determined as described previously (18).
Enzyme Assays--
Aspartate transcarbamoylase assay was assayed
by the method of Prescott and Jones (12) as modified by Pastra-Landis
et al. (32). Typically 50 ng of the purified protein was
assayed at 37 °C for 20 min in a 1.0-ml assay mixture consisting of
5 mM carbamoyl phosphate and 20 mM aspartate in
50 mM Tris-HCl, pH 8.5. Alternatively, a radioactive assay
described previously (33) that uses [14C]aspartate as a
substrate was used to measure aspartate transcarbamoylase activity.
Unless specifically noted, the reaction was initiated by the addition
of carbamoyl phosphate to the otherwise complete assay mixture. A unit
of enzyme activity is defined as µmol/h/mg.
To determine whether inhibition by two nucleotides is additive,
antagonistic, or synergistic, the extent of inhibition was determined
in the presence of one and both effectors following the approach
described by Webb (34). The activity in the presence of an inhibitor 1 is given by the expression a1 = (1 i1), where i is the fractional
inhibition. In the presence of two inhibitors that function
independently, inhibition should be additive, and the activity
(a12) would be the product of the activities or
a12 = (1 i1)(1 i2) = i1 + i2 i1i2. Smaller and larger
values of a12 would be indicative of antagonist
or synergistic inhibition, respectively. Additive or synergistic
inhibition is an indication that the inhibitors bind to different sites
on the enzyme. For these experiments, one inhibitor was held constant
at a concentration giving ~50% inhibition, whereas the second was
varied over it effective range.
The pH activity profile was determined using a three-part buffer (35)
consisting of 0.05 M MES, 0.1 M diethanolamine,
and 0.05 M N-ethylmorpholine. A least squares
fit of the substrate saturation data to the Michaelis-Menten or Hill
equation was carried out using either Kaleidagraph 2.1 (Abelbeck
software) or Scientist (Micromath). The concentration of free ATP was
calculated from the total concentration of ATP and Mg2+ ion
using published (36) stability constants.
Cell Growth and Induction--
P. aeruginosa ATCase
is expressed constitutively in EK1104 cells transformed with pA10 grown
in M9 media supplemented with 0.4% glucose, 0.1% casamino acids, 0.5 µg/ml ZnSO4·7H2O, 0.1 mM CaCl2, 0.5 µg/ml FeSO4·7H2O, 1 mM MgSO47H2O, 5 µg/ml thiamin, 0.001% tryptophan. Alternatively, the recombinant protein was obtained
from BL21(DE3) E. coli cells transformed with pJV34, a
plasmid constructed as described under "Results." The competent host cells were prepared using the method of Huff et al.
(37). The expression of the enzyme in the pJV34 transformants was under control of the T7 promoter. A 1-ml culture of exponentially growing transformed cells obtained from a single colony was used to inoculate 100 ml of YT media supplemented with 100 µg/ml ampicillin. The cells
were grown at 37 °C in a rotary shaker (225 rpm) at 37 °C to an
absorbance of 0.4-0.6. The expression of the protein was then induced
by the addition of IPTG to a concentration of 400 µM. The
cells were then grown for an additional 2 h prior to harvesting.
Purification of the Recombinant Proteins--
For purification
of the recombinant protein from EK1104 cells transformed with pA10,
85 g of packed cells were suspended in 100 ml of sonication
buffer, 50 mM Tris, pH 8.5, 2 mM
2-mercaptoethanol, and 0.02 mM ZnCl2 at
4 °C. The suspension was sonicated on ice and then centrifuged for
15 min at 31,000 × g to remove the cellular debris.
After clarifying the extract by centrifugation at 48,000 × g for 90 min, the supernatant (128 ml) was fractionated with ammonium sulfate. Protein precipitating between 30 and 45% ammonium sulfate saturation was resuspended in 6 ml of the sonication buffer and
dialyzed exhaustively against the same buffer. The dialyzed protein was
chromatographed on a 26 × 1.6-cm Sepharose Q fast-flow column
equilibrated in 50 mM Tris-HCl, pH 8.5, at a flow rate 1.0 ml/min. After washing the column overnight with 50 ml of 0.25 M NaCl in 50 mM Tris-HCl, pH 8.5, the protein
was eluted with a linear gradient of 0.25-0.6 M NaCl in
the same buffer. Fractions containing ATCase activity were pooled, and
glycerol was added to a final concentration of 10%. The preparation
was concentrated using an Amicon Protein Concentrator under nitrogen to
a final volume of 20 ml. The concentrated sample was chromatographed on a 1.9 × 90-cm Sephacryl 300HR column equilibrated and eluted with 50 mM Tris-HCl, pH 8.5, 10% glycerol at a flow rate of 12 ml/h. The active fractions were then applied to a 6 × 1.2-cm
hydroxylapatite column and eluted with a 0-0.2 M gradient
of potassium phosphate in the same buffer.
For purification of recombinant ATCase from pJV34 BL21(DE3)
transformants, 500 mg of packed cells obtained from a 100-ml culture were washed once with 2 ml of 50 mM Tris-HCl, pH 8.5, 10%
glycerol containing 200 mM NaCl and resuspended in 2 ml of
the same buffer. The cells were disrupted using a Branson sonifier. The
sonication protocol consisted of four 20-s bursts with a microtip set
at 50% duty cycle, output 5.5, with a 1-min cooling period on ice between each burst. The cellular debris was removed by centrifugation 12,000 × g for 4 min. The supernatant was immediately
applied to 1 ml of ProBondTM nickel matrix (Invitrogen)
that had been equilibrated with 50 mM Tris-HCl, pH 8.5, 10% glycerol, 200 mM NaCl. The column was successively
washed with 2 ml of 25 mM imidazole, 2 ml of 50 mM imidazole, and 2 ml of 200 mM imidazole in
the same buffer. The fractions containing ATCase were pooled and
dialyzed against 50 mM Tris-HCl, pH 8.5, 10% glycerol at
4 °C and then stored at 80 °C.
 |
RESULTS |
Expression and Purification of P. aeruginosa
ATCase--
Initially, recombinant P. aeruginosa ATCase was
isolated from E. coli transformed with the plasmid pA10
following the five-step protocol described under "Experimental
Procedures." The final yield (Table I)
starting with 85 g of packed cells was 400 µg. The specific
activity of 525 µmol/h/mg of the homogeneous protein was appreciably
lower than the values observed for ATCase isolated from other bacterial
sources.
Because of the low specific enzymatic activity, the low yield of
protein, and the laborious isolation procedure, the protein was
recloned into a high expression system that appends a His tag affinity
label to the amino end of the catalytic subunit to facilitate
purification. The 2.4-kb PstI fragment of pA10 containing the entire P. aeruginosa ATCase coding sequence was inserted
(Fig. 1) into the expression vector
pRSETC. The resulting plasmid, pJV34, encodes the 45-kDa pDHO subunit
and the 36-kDa catalytic subunit with a 3-kDa chain segment containing
six histidines fused to the amino end. Following transformation into
E. coli strain BL21(DE3), expression of the recombinant
protein was induced with IPTG. P. aeruginosa ATCase was
produced at very high levels (Fig. 2,
lane Ex), but approximately two-thirds of the protein was
recovered in the pellet following low speed centrifugation. The ATCase
in the supernatant fraction (Fig. 2, lane Su) was purified
in a single step by chromatography on a Ni2+ affinity
column. After washing the column to remove non-specifically bound
proteins, the ATCase was eluted with 200 mM imidazole as a
homogeneous protein (Fig. 2, lane ATC) consisting of 45- and 36-kDa polypeptides. Electrophoresis on non-denaturing polyacrylamide gels revealed a single species that migrated appreciably more slowly
than E. coli ATCase (data not shown), a result consistent with the dodecameric structure (23) of the Pseudomonas
enzyme. A yield (Table I) of 3 mg of homogeneous protein was obtained from a 100-ml culture (0.5 g of packed cells). The final specific activity of the purified ATCase was 12,500 µmol/h/mg, comparable with
that observed (28) for the E. coli enzyme. The
histidine-rich segment at the amino end of the catalytic chain could be
removed by enterokinase protease digestion. The cleaved catalytic chain was the same size as the wild type enzyme, but the first 8 residues at
the amino end differed in sequence (Fig. 1) as a consequence of the
cloning procedure. The specific activity of the ATCase isolated using
the pJV34 expression system was 51-fold higher that the recombinant
protein isolated from the pA10 transformants.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Cloning and expression of P. aeruginosa ATCase. The plasmid pA10 (45) was
constructed by inserting a 3.5-kb XhoI fragment of the
cosmid 011125 into the SalI site of pUC18 and produced low
levels of functional P. aeruginosa ATCase. To increase the
level of expression, pA10 was digested with PstI, and the
2.4-kbp fragment was inserted into the PstI site in the
polycloning region of the vector pRSETC. In this system, expression is
under control of the T7 promoter. Transformation of the resulting
plasmid pJV34 into E. coli BL21(DE3) and induction with IPTG
resulted in the expression of high levels of the P. aeruginosa enzyme. The catalytic chain has a 38-residue chain
segment containing six consecutive histidine residues and enterokinase
cleavage site fused to the amino end of the polypeptide. The first 8 residues of the native catalytic chain are replaced by 8 residues from
the fusion peptide.
|
|

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 2.
Expression and purification of
P. aeruginosa ATCase. A, the
pJV34/E. coli BL21(DE3) transformants produced high levels
of P. aeruginosa ATCase representing 70% of the total
protein in the cell extract (Ex). The soluble fraction
(Su), obtained by centrifugation at 12,000 × g for 4 min, was applied to a 1.0-ml Ni2+
affinity column. The column was washed with 3 column volumes
(E1, E2, and E3) of 50 mM
Tris-HCl, pH 8.5, 10% glycerol, 200 mM NaCl, and 25 mM imidazole. The purified protein (ATC) was
eluted with the same buffer except that the concentration of imidazole
was increased to 200 mM. Molecular weight standards
(St) are also shown, as is a more concentrated sample of the
protein (ATC) on the adjacent gel. B,
purified ATCase, at a final concentration of 1 mg/ml, was crystallized
by the hanging drop method in 0.1 M citrate, pH 5.0, 10%
6K polyethylene glycol. The crystals, thick trapezoidal plates, grew to
0.2-mm in the longest dimension within 1 week.
|
|
The purified protein was crystallized by the hanging drop method (38).
Equal volumes (2 µl) of the purified protein at a concentration of 1 mg/ml in 50 mM Tris-HCl, pH 8.5, was mixed with the
precipitin, 100 mM citrate, pH 5, and 10% 6K polyethylene glycol. The resulting crystals (Fig. 2B), well formed
half-hexagonal plates, 0.3-mm in the longest dimension, set the stage
for future x-ray structure diffraction studies.
Cloning the Catalytic and Pseudo-DHO Subunits--
The pseudo-DHO
coding sequence was deleted from pJV34 by restriction with
AspI and HindIII and religation. Transformation of the resulting construct, pJV30, into BL21 cells, resulted in the
expression of high levels of the P. aeruginosa catalytic
chain. However, all of the protein was present in insoluble inclusion bodies and exhibited no catalytic activity. The insoluble protein was
dissolved in 8 M urea and then dialyzed against 50 mM Tris-HCl, pH 8.5, 10% glycerol. The protein remained in
solution after removal of the denaturant, suggesting that it had
refolded into a stable, soluble species, but the enzymatic activity was
not recovered.
In another series of experiments, the catalytic chain coding sequence
in pJV34 was deleted by digestion with XhoI and
HindIII. High levels of the isolated pDHO subunit were
expressed when the truncated plasmid was transformed into BL21(DE3)
cells.2 This species was
completely soluble but, as expected, had no catalytic activity.
In an attempt to reconstitute the native complex, 70 ng of the refolded
catalytic subunit was titrated with increasing amounts (8-160 ng) of
the soluble pDHO subunit (data not shown). Because only the catalytic
chain carried the His tag affinity label, coelution of the 36- and
45-kDa subunits from the Ni2+ affinity column indicated
that a stable complex was formed. However, the reconstituted complex
also lacked catalytic activity.
The holoenzyme was incubated in various concentrations of urea (0.2-2
M), and the chromatographed on the Ni2+ column
equilibrated with the same concentration of urea. The enzyme
dissociated by 2 M urea, as indicated by the elution of the
45-kDa pDHO subunits and retention of the 36-kDa catalytic chains on
the column, but the catalytic activity was lost. Collectively, these
results suggest that the isolated catalytic subunit must be associated
with pDHO subunits to be catalytically active.
When ATCase was completely denatured in 8 M urea and then
refolded by dialysis against a buffer lacking the denaturant, a complex
consisting of stoichiometric amounts of the two ATCase subunits was
recovered from the affinity column (Fig.
3A), but it was also inactive.
Gel filtration chromatography (Fig. 3B) showed that the
molecular mass of the reconstituted complex was similar to that of the
native dodecamer (480 kDa), although the peak was broader, possibly an
indication of the presence of higher and lower oligomers. Thus,
although dissociated and denatured ATCase can be reconstituted into a
complex resembling the native enzyme in size and subunit composition,
it has not been possible to restore catalytic activity.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Reconstitution of urea-denatured ATCase.
A, P. aeruginosa ATCase (500 µg in 1 ml),
dissociated and denatured as described in the text, was refolded by
dialysis against two changes of 0.05 M Tris-HCl, pH 8.5, 10% glycerol. The protein was fractionated on a Ni2+
affinity column as described in the legend to Fig. 2 and analyzed by
SDS-gel electrophoresis. Both subunits were retained on the column with
only small amounts eluting in the flow-through and wash fractions
(lanes 2-5). Both subunits were eluted with 200 mM imidazole in the same buffer (lane 6) with a
stoichiometry that closely resembled that of the native protein
(lane 1). B, native P. aeruginosa
ATCase was chromatographed on a Sepharose 6 column equilibrated with
0.05 M Tris-HCl, pH 8.5, 10% glycerol and eluted with the
same buffer at a flow rate of 1 ml/min. The elution profile of the
native protein (dashed line) was obtained by measuring the
absorbance at 280 nm. A second sample of the enzyme (1 mg/0.5 ml) was
denatured in 8 M urea for 12 h and then refolded by
dialysis two times against 0.05 M Tris-HCl, pH 8.5, 10%
glycerol. A sample of 0.44 mg of the refolded protein (solid
line) was chromatographed on the same Superose 6 column as
described for the native enzyme. The column profile (dash dotted
lines) of two proteins derived from an invertebrate hemoglobin (a
gift of S. Vinogradov) is also shown for comparison.
|
|
Steady State Kinetics--
The aspartate saturation curve of
P. aeruginosa ATCase (Fig.
4A) was hyperbolic. As
observed for the isolated E. coli ATCase catalytic subunit,
there was no indication of cooperative substrate binding, but high
concentrations of aspartate partially inhibited the enzyme (not shown).
A least squares fit of the data gave a Km for
aspartate of 2.6 mM and a Vmax, of
12,500 µmol/h/mg (Table II). The
carbamoyl phosphate saturation curve (Fig. 4B) was also
hyperbolic, but in this case there was no apparent substrate inhibition. The Km for carbamoyl phosphate was 0.49 mM. The pH optimum for catalysis was measured using
saturating concentrations of aspartate and carbamoyl phosphate.
Catalytic activity increased steeply as the pH increased from pH 7 to
8.5 and then began to decrease. A fit of the plot of
ln(Vmax) against pH (not shown) to the Dixon
equation gave a pKa of 8.1 for the acidic limb of
the curve. The pH-rate profile of the P. aeruginosa enzyme closely resembles that of the E. coli ATCase catalytic
subunit but is very different from bimodal pH dependence of the
allosteric E. coli holoenzyme (39).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Substrate saturation curves for P. aeruginosa ATCase. A, the ATCase activity
was measured with aspartate as the variable substrate and carbamoyl
phosphate fixed at 5 mM in the absence of nucleotide
triphosphates ( ) and in the presence of 2 µM ( ), 4 µM ( ), and 6 µM ( ) ATP.
B, the ATCase activity was measured with carbamoyl
phosphate as the variable substrate and aspartate fixed at 20 mM. For two of the curves, the assay was initiated with
aspartate in the absence of nucleotides ( ) and the presence of 6 µM ATP ( ). For the other two curves, the assay was
initiated with carbamoyl phosphate without ATP ( ) and in the
presence of 6 µM ATP ( ).
|
|
Nucleotide Inhibition--
As reported previously (22, 23),
P. aeruginosa ATCase was strongly inhibited by CTP,
UTP, ATP, and GTP (Fig. 5A)
but not the corresponding nucleotide monophosphates or nucleotide
diphosphates (not shown). Measurement of the residual ATCase activity
as the concentration of the nucleotide triphosphates was varied (Fig. 5B) showed the enzyme was inhibited 50% at nucleotide
concentrations of about 2 µM and that all of the
nucleotide triphosphates bound to the enzyme with approximately equal
affinity. The apparent dissociation constant was 4 µM, a
value far below the reported concentration of all of these nucleotides
(40) in the P. aeruginosa cells.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of nucleotides on the ATCase
activity. A, the effect of nucleotide mono- and
triphosphates at a concentration of 1 mM on the catalytic
activity of P. aeruginosa ATCase assayed in the presence of
5 mM carbamoyl phosphate and 20 mM aspartate in
50 mM Tris-HCl, pH 8.5. B, the residual
ATCase activity was measured using the conditions in A in
the presence of a variable concentration of ATP ( ), CTP ( ), UTP
( ), and GTP ( ).
|
|
The approach devised by Webb (34) was adopted to determine whether the
ATCase inhibition produced by combinations of two nucleotides is
additive, antagonistic, or synergistic. In this method, one inhibitor
is held constant, whereas the other is varied over its effective range.
In one series of experiments, the ATP concentration was held at 1 µM, whereas the UTP concentration ranged from 1 to 10 µM. Alternatively, the UTP concentration was held
constant at 1 µM, whereas the ATP was varied from 1 to 10 µM. In both experiments at all concentrations, the
observed fractional inhibition in the presence of both inhibitors
(i12) was always less than that predicted from
the fractional inhibition i1 and i2 of the individual inhibitors acting
independently (i.e. i12 = i1 + i2 i1i2). This result,
indicative of antagonistic inhibition (34), would be obtained if both
nucleotides bind to the same site on the enzyme.
Effect of Nucleotide on the Steady State Kinetics--
Nucleotide
triphosphates dramatically altered the steady state kinetics. In the
presence of 2 µM ATP, the aspartate saturation curve
(Fig. 4A) became strongly sigmoidal. The concentration of aspartate required for half-saturation, [S]0.5, increased
from 2.6 to 14.0 mM, and the effects were even more
pronounced at 4 and 6 µM ATP. ATP had little effect on
Vmax. These curves were fit to the Hill equation
and gave Hill coefficients (Table II) that ranged from 7.5 to 10.
Titration with the bisubstrate analog,
N-phosphonacetyl-L-asparate (PALA), was used to
determine whether the enzyme exhibits true cooperative substrate
binding. When the E. coli holoenzyme is assayed using
subsaturating concentrations of aspartate and carbamoyl phosphate, PALA
appreciably activates (10-20-fold) at low concentrations and then
inhibits the enzyme as the concentration of PALA approaches saturation.
This unusual response has been interpreted (41) to be a consequence of
the T to R transition that the enzyme undergoes upon substrate binding.
The binding of PALA to one site on the enzyme is sufficient to shift
the equilibrium to the high affinity, active R state, whereas the
activity is lost as PALA binds to the remaining active sites on the
enzyme. Initial activation followed by inhibition by carbamoyl
phosphate analog, phosphonoacetate, was also observed for the E. coli enzyme.
However, in assays (not shown) conducted using 5 mM
carbamoyl phosphate and 1 mM aspartate, the P. aeruginosa enzyme was inhibited at all concentrations of PALA.
Similarly, phosphonoacetate inhibited at all concentrations tested
when the assay contained 20 mM aspartate and 40 µM, carbamoyl phosphate. Neither compound activated
the P. aeruginosa ATCase, a result consistent with the
hyperbolic saturation curves observed in the absence of nucleotides.
In contrast, when 2 µM ATP was present, the response to
PALA (Fig. 6) was found to be
qualitatively similar to that exhibited by the native E. coli enzyme. The activity increased with increasing inhibitor
concentrations up to a peak corresponding to a 2.4-fold activation at 1 nM PALA. The activity then began to decrease with increasing PALA concentration. These results indicated that the sigmoidal saturation kinetics observed in the presence of ATP can be
attributed in part to cooperative interactions between the catalytic
sites. However, the PALA activation was much less than that observed
for E. coli ATCase despite the very high Hill coefficients (Table II), suggesting that other factors are involved. As
discussed below, conformational changes induced by nucleotide binding
are only slowly reversed. This hysteretic phenomenon is likely to be
primarily responsible for the sigmoidal aspartate saturation
curves.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
The effect of PALA on the activity of
P. aeruginosa ATCase. The ATCase was
assayed using 5 mM carbamoyl phosphate and either 8 ( ) or 12 mM ( ) aspartate and a variable
concentration of the bisubstrate inhibitor, PALA, in the presence of 2 µM ATP. In the absence of ATP, PALA inhibited the enzyme
at all concentrations (data not shown).
|
|
Order of Addition of Substrates and Effectors--
Unexpectedly,
ATP had no effect on the carbamoyl phosphate saturation curves (Fig.
4B). The carbamoyl phosphate concentration in the assays for
the aspartate saturation curve was 5 mM, whereas the
aspartate concentrations used for the carbamoyl phosphate saturation
curve was 20 mM. At the common point in these two plots (Fig. 4, A and B), 20 mM aspartate
and 5 mM carbamoyl phosphate, the velocity was very
different although the composition of the assay mixture was identical.
The only difference between the assays for these two experiments was
the order of addition of the substrate. The aspartate and carbamoyl
phosphate saturation curves were initiated by the addition of carbamoyl
phosphate and aspartate, respectively, to the complete assay mixture.
ATP did not inhibit the enzyme when the assays for the carbamoyl
phosphate saturation curve (Fig. 4B) were initiated by the
addition of aspartate. If, instead, the carbamoyl phosphate assays were
initiated with carbamoyl phosphate (Fig. 4B), the saturation
curve in the absence of nucleotides was found to be superimposable on
the curve obtained when the reaction was initiated with aspartate, but
the activity is inhibited by 6 µM ATP to the same extent
as that observed in the aspartate saturation curve.
To assess further whether the order of addition altered the observed
activity, a series of assays were conducted in which the enzyme,
substrates, and effectors were mixed in different sequences. The
results (Table III) indicate that ATP is
a potent inhibitor only when mixed with the enzyme in the absence of
carbamoyl phosphate, regardless of whether the reaction is initiated
with aspartate or carbamoyl phosphate. If carbamoyl phosphate and
enzyme are first mixed, ATP does not inhibit the reaction. If both
carbamoyl phosphate and ATP were present when the enzyme was added to
the assay mixture, the observed catalytic activity was the same as that
observed in the absence of the nucleotide, indicating that enzyme binds
carbamoyl phosphate preferentially. The effect of ATP is not a
consequence of its reaction with the enzyme or with any of the
substrates because the non-hydrolyzable ATP analog, AMP-PNP, exhibited
identical effects on the activity of the enzyme.
View this table:
[in this window]
[in a new window]
|
Table III
Effect of order of addition of substrates and nucleotides
The components of the assay mixture were added to a final concentration
of 0.05 µg/ml P. aeruginosa ATCase, 20 mM
aspartate, 5 mM carbamoyl phosphate, and 6 µATP.
|
|
Effect of Magnesium--
Excess MgCl2 abolished the
inhibition of P. aeruginosa ATCase by ATP. In the absence of
nucleotide, Mg2+ ion alone in concentrations ranging from 1 µM to 1 mM had no effect on the catalytic
activity (data not shown). However, if ATP and Mg2+ were
present in equimolar concentrations, ATP no longer altered the activity
of the enzyme. This result suggested that ATP but not the MgATP complex
was responsible for inhibition. To test this interpretation, the
activity of the enzyme was measured in the presence of 2 µM ATP and increasing concentrations of
MgCl2. A plot of the residual enzyme activity (Fig.
7) showed that inhibition closely
paralleled the concentration of free ATP calculated from the
concentration of ATP and Mg2+ in the assay mixture.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
The effect of Mg2+ on ATP
inhibition of P. aeruginosa ATCase. The ATCase
activity ( ) was assayed as described under "Experimental
Procedures" in the presence of 6 µM ATP and a variable
concentration of MgCl2. The concentration of free ATP ( )
was calculated from the total concentration of ATP and the
MgCl2 concentration as described by Perrin and
Sharma (36). High concentration of MgCl2 partially
inhibited the activity of the enzyme, so the dotted line was
calculated using the Vmax obtained in the
absence of ATP and MgCl2. The crossover point of the two
curves corresponds to 50% inhibition and 50% free ATP suggesting that
only free ATP inhibits the enzyme.
|
|
Binding of an ATP Analog--
The binding of ATP fluorescent
analog, 1,N6-ethenoadenosine 5'-triphosphate
( ATP), to P. aeruginosa ATCase was measured by fluorescence spectroscopy. The fluorescence intensity increased with
increasing concentrations of ATP added to the enzyme and exhibited
normal saturation kinetics (not shown). The dissociation constant for
the ATP-ATCase complex was 4 µM, close to the value obtained from the ATP inhibition kinetics indicating that ATP and
ATP bind to the enzyme with comparable affinity. In the absence of
Mg2+, ATP inhibited the enzyme activity to the same
extent when assays were initiated by the additional of carbamoyl
phosphate. The addition of MgCl2 to ATP-ATCase (Fig.
8) reversed the increase in fluorescence suggesting Mg2+ displaced bound ATP and that the
Mg2+ complex, like MgATP, does not bind to the enzyme. The
fluorescence change was completely reversed as the concentration of
MgCl2 approached 30 µM, the concentration of
ATP in the reaction mixture. Similarly, ATP displaced the bound
fluorescent analog, although in this case the curve is distinctly
sigmoidal reflecting the difficulty of dislodging ATP from the
enzyme. The addition of carbamoyl phosphate to the ATP-ATCase
complex did not entirely displace the bound analog judging from the
small change in the fluorescence intensity observed over a range of
carbamoyl phosphate of 0-5000 µM. However, the
preincubation of the enzyme with carbamoyl phosphate reduced subsequent
binding of the ATP analog.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
The binding of ATP
to P. aeruginosa ATCase. The
fluorescence of a mixture of 30 µM ATP and 6.2 µM of purified P. aeruginosa ATCase was
measured using an excitation wavelength of 300 nm and an emission
wavelength of 408 nm. The decrease in fluorescence was measured with
increasing carbamoyl phosphate ( ), MgCl2 ( ),
or ATP ( ) concentration.
|
|
 |
DISCUSSION |
P. aeruginosa ATCase is a representative of the class A
aspartate transcarbamoylase first identified by Jones and colleagues (22). The class B and C ATCases have been well characterized, but
progress on the class C enzymes has been hampered by the lack of
adequate amounts of the purified protein. The level of expression of
the protein in P. aeruginosa cells is low, and the
purification procedure involves many steps, and the protein is
relatively unstable so that the purified enzyme has low specific enzyme
activity. We report here the cloning and overexpression of P. aeruginosa enzyme. The enzyme carries a His tag appended to the
amino end of the catalytic subunit that allows the homogeneous protein
to be recovered in a single step on a Ni2+ affinity column.
The observation that the purified enzyme had a specific activity that
was 51-fold higher than the protein isolated from pA10 transformants
and 11-fold higher that the protein directly purified (23) from
P. fluorescens cells underscores the
efficacy of a rapid isolation procedure.
The complete conservation in P. aeruginosa ATCase of all of
the residues implicated in catalysis in the E. coli ATCase
catalytic subunit, as well as an identical pH dependence, suggests that the two enzymes share a common catalytic mechanism. E. coli
ATCase, a class B enzyme, can be dissociated by mercurials into two
enzymatically active trimers and three regulatory dimers. Structural
studies subsequently showed that all of the residues required for
substrate binding and catalysis are present within the catalytic chain
and that the active site is a composite composed of residues on two adjacent catalytic chains within the trimer. The class C ATCase from
B. subtilis (19) and the isolated ATCase domain of the mammalian multifunctional protein CAD (42, 43) are catalytically active
trimers. Thus, in these enzymes, the trimer is necessary and sufficient
for catalysis.
In contrast, previous attempts (25) to express Pseudomonas
catalytic subunits by deletion of the pDHO gene (pyrC')
yielded plasmids that, unlike the parental constructs, were unable to complement E. coli strains deficient in ATCase. This
observation led to the suggestion that, unlike the catalytic subunit of
E. coli ATCase and the class C enzymes, the P. aeruginosa catalytic subunit is inactive in the absence of the
pDHO chains. Similarly in this study, deletion of the pyrC'
gene in the pJV30 construct led to the expression of large amounts of
catalytic subunit, but all of the protein was found in inclusion bodies
and was inactive. This result suggested that the catalytic subunit
cannot fold properly in the absence of the pDHO subunit but did not
directly address the question as to whether the isolated catalytic
subunit, once folded, required the pDHO subunit for activity. The
insoluble protein was solubilized in 8 M urea and refolded
into soluble trimers but did not recover catalytic activity. The
addition of the pDHO polypeptide to the refolded catalytic trimer
resulted in the formation of a stable complex but did not restore
catalytic activity. These results suggest that in the absence the
catalytic chains are unable to assume the tertiary structure required
for activity. This conclusion remains tentative as it is possible that
conditions could be found that result in proper folding of the isolated
catalytic subunit in catalytically active form, but nevertheless it is
true that coexpression of the two subunits facilitates the formation of
native complex.
P. aeruginosa ATCase is exquisitely sensitive to micromolar
concentration of all the nucleotide triphosphates. The intracellular concentrations of ATP, CTP, UTP, and GTP have been found (40) to be
4.4, 0.8, 2.1, and 3.0 mM respectively, in P. putida cells, so it is difficult to imagine circumstances under
which ATCase can be catalytically active. The regulatory logic of the
system was also puzzling. Inhibition by purine nucleotides, as well as pyrimidine nucleotides, while not unprecedented, is difficult to
rationalize. In E. coli ATCase, for example, ATP is an
allosteric activator that signals the availability of purine
nucleotides and coordinates the flux through the pyrimidine and purine
pathways. Also the Hill coefficients of the P. aeruginosa enzyme measured in the presence of ATP are much
higher than those of E. coli ATCase. The observation that
PALA activates the enzyme at low concentration confirms that weak
cooperative transitions between active sites do occur, but these alone
cannot account for the strongly sigmoidal saturation curves.
The unusual kinetics can be explained by two additional observations.
First, the inhibition is abolished by Mg2+ and the extent
of inhibition exhibits a convincing inverse correlation with the
concentration of the MgATP complex. Thus, it is likely that only free
ATP can bind to the enzyme. Neither the total magnesium ion
concentration nor the concentration of free nucleotide triphosphates in
the cell are known. However, it is possible that these nucleotides exist primarily as the Mg2+ complex, in which case
inhibition of ATCase inhibition would be attenuated. Thus, the
Mg2+ effectively buffers the nucleotides and the activity
of the enzyme in vivo probably depends on the
precise balance of free nucleotides and their metal ion complexes.
Second, the inhibition is observed only when the reaction is initiated
with carbamoyl phosphate. No inhibition is observed if the enzyme is
first preincubated with this substrate, a result that suggests that the
nucleotides may bind near the active site. In support of this
interpretation, chemical modification with the ATP analog, FSBA, showed
(23) that the nucleotides bind to the catalytic subunit. Moreover,
deletion mutants lacking the first 34 residues at the amino end of the
P. putida catalytic chain have been found (25) to be
insensitive to nucleotides, indicating that this region of the molecule
participates in feedback inhibition. Much of this chain segment may
well be important, although 8 of these residues have been substituted
in the construct described here, with the complete retention of
nucleotide sensitivity. The lack of discrimination between nucleotide
bases and the failure of mono- and diphosphate nucleotide to inhibit
the enzyme might suggest that the -phosphate moiety of the
triphosphates may compete with carbamoyl phosphate in binding at the
active site. Nucleotide triphosphates, pyrophosphate, and other
phosphate compounds have been shown to be competitive inhibitors of
carbamoyl phosphate binding to the E. coli enzyme. However,
the observation that the inhibition constants are in the micromolar
range, not in the millimolar range as observed for the E. coli enzyme (44), and that ATP inhibition is non-competitive, not
competitive, with respect to carbamoyl phosphate argues against this
interpretation. Thus, it is likely that there is a high affinity
nucleotide-binding site on the catalytic chain distinct from the active site.
The interaction of ATP with the enzyme was investigated in steady state
kinetic studies and binding studies using ATP, a fluorescent analog
that binds with comparable affinity and elicits the same inactivation
as ATP. Once bound the nucleotide triphosphate is tightly associated
with the enzyme and is not in rapid equilibrium with carbamoyl
phosphate. As the nucleotide is slowly displaced from the enzyme by
high concentration of carbamoyl phosphate, the activity is gradually
restored. This explanation accounts for the extreme sigmoidicity of the
aspartate saturation curves. Conversely, when carbamoyl phosphate is
bound to the enzyme, the nucleotide binds weakly and cannot inhibit the
enzyme. The on constant for the association of nucleotides with the
enzyme, as well as the off constant, must be slow, because when both
the nucleotide and carbamoyl phosphate are simultaneously present, the
nucleotide does not inhibit the enzyme.
Many eubacteria, including P. aeruginosa, have a single
CPSase (46) that provides carbamoyl phosphate for both pyrimidine and
arginine biosynthesis. In addition (47), P. aeruginosa has an arginine deiminase pathway (Fig.
9) that allows the organism to use
arginine as an energy source. The latter pathway is considered to be
particularly important during anaerobic growth (48). Carbamoyl phosphate, produced by the concerted action of arginine deiminase and
catabolic ornithine decarboxylase, is converted to ATP,
CO2, and NH by carbamate
kinase. Thus, there are two routes to carbamoyl phosphate synthesis and
three fates for the intermediate once formed. Consequently, the
regulation of carbamoyl phosphate is complex and not well understood.
When the cells grow in a medium rich in nucleotides and a plentiful source of energy-producing metabolites, the intracellular concentration of NTPs is high. It may be that inhibition of ATCase occurs if the
concentration of free NTPs exceeds that of available Mg2+,
thus blocking further de novo synthesis of pyrimidines. The elevated ATP levels also inhibit two enzymes of the arginine deiminase pathway (46, 47). It is interesting that Mg2+ ion activates
arginine deaminase by decreasing the Km value for
arginine 12-fold (49); thus limiting Mg2+ when NTPs are
abundant would down-regulate the arginine deiminase pathway as well as
the pyrimidine biosynthesis. Arginine biosynthesis can proceed unless
the level of citrulline is too low to sustain further arginine
synthesis and activate CPSase. When the energy charge is low,
inhibition of the arginine deiminase pathway is relieved allowing the
organism to extract energy from arginine catabolism. Partial UMP
inhibition of CPSase and limiting ATP would be expected to decrease the
synthesis of carbamoyl phosphate for pyrimidine biosynthesis. However,
carbamoyl phosphate is also an intermediate in the arginine deiminase
pathway and in principle might be expected to enter the pyrimidine
pathway especially because the Km value for
carbamoyl phosphate of ATCase (0.4 mM) reported here is
6-fold lower than that of carbamate kinase (5 mM at 2 mM ADP) (9). This crossover apparently does not occur in
the cell because carB mutants, deficient in CPSase, require uracil for growth (50). This observation suggests that the carbamoyl phosphate produced by arginine catabolism is unavailable for pyrimidine biosynthesis. Thus, there must be other as yet undiscovered mechanisms that control carbamoyl phosphate entry into the pyrimidine and arginine
biosynthetic pathways or sequester the intermediate formed by the
arginine deiminase pathway.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 9.
Carbamoyl phosphate metabolism in
P. aeruginosa. The enzymes involved in
carbamoyl phosphate formation and utilization include carbamoyl
phosphate synthetase (CPSase), aspartate transcarbamoylase
(ATCase), anabolic ornithine transcarbamoylase
(OTCase), and the enzymes of the arginine deiminase pathway,
arginine deiminase (ADase), catabolic ornithine
transcarbamoylase (cOTCase), and carbamate kinase
(CKase). The allosteric regulation of these enzymes by
inhibitors ( ) and activators (+) is represented by dotted
lines.
|
|
In summary, using the construct described here, P. aeruginosa ATCase can be rapidly purified to homogeneity in
quantities that make possible, for the first time, structure-function
studies of any class A ATCase. The pDHO subunit is needed for optimal folding of the ATCase and perhaps to stabilize the optimal conformation once the enzyme has folded. Kinetic studies demonstrated that free
nucleotides, but not the Mg2+ complex, bind to the enzyme
and that carbamoyl phosphate antagonizes nucleotide binding. These
observations provide an explanation for the unusual inhibition by a low
concentrations of a broad range of nucleotide triphosphates, although
the physiological role remains to be established. However, the effect
of metabolites on the catalytic activity of Pseudomonas
ATCase is distinctly different from that reported for ATCase from other
prokaryotic and all eukaryotic organisms, and thus this enzyme may
represent a potential target for drug design. For example, a
cell-permeable nucleotide analog that inhibits P. aeruginosa
ATCase in the presence of Mg2+ would be expected to abolish
selectively pyrimidine biosynthesis in the microorganism.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Askar Kuchumov and Dr. Serge
Vinogradov for help and advice on the fast protein liquid
chromatography studies.
 |
FOOTNOTES |
*
This work was supported by National Science Foundation Grant
MCB-9810325, National Science Foundation Postdoctoral Fellowship INT9203314, and National Institutes of Health Grant GM47399.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) L19649.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology, Wayne State University School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201. Tel.: 313-577-1016; Fax: 313-577-2765; E-mail: devans@cmb.biosci.wayne.edu.
Published, JBC Papers in Press, April 16, 2002, DOI 10.1074/jbc.M200009200
2
N. Sahay, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ATCase, aspartate
transcarbamoylase;
ATP, 1,N6-ethenoadenosine
5'-triphosphate: pDHO, pseudo-dihydroorotase, an inactive homolog of
dihydroorotase;
AMP-PNP, 5'-adenylylimidodiphosphate;
MES, 4-morpholineethanesulfonic acid;
PALA, N-phosphonoacetyl-L-aspartate;
CPSase, carbamoyl phosphate synthetase;
FSBA, 5'-p-fluorosulfonylbenzoyladenosine.
 |
REFERENCES |
| 1.
|
Palmer, D.,
and Bender, C.
(1993)
Appl. Environ. Microbiol.
59,
1619-1626[Abstract/Free Full Text]
|
| 2.
|
Zhang, Y.,
Rowley, K.,
and Patil, S.
(1993)
J. Bacteriol.
175,
6451-6458[Abstract/Free Full Text]
|
| 3.
|
Preston, M.,
Kernack, K.,
and Berk, R.
(1993)
Infect. Immun.
61,
2713-2716[Abstract/Free Full Text]
|
| 4.
|
Hobden, J.,
Hill, J.,
Engel, L.,
and Ocallaghan, R.
(1993)
Antimicrob. Agents
37,
1856-1859
|
| 5.
|
Tredget, E.,
Shankowsky, H.,
Joffe, A.,
Inkson, T.,
Volpel, K.,
Paranchych, W.,
Kibsey, P.,
Alton, J.,
and Burke, J.
(1992)
Clin. Infect. Dis.
15,
941-949[Medline]
[Order article via Infotrieve]
|
| 6.
|
Xu, G.,
and West, T.
(1992)
J. Gen. Microbiol.
138,
2459-2463
|
| 7.
|
Condon, S.,
Collins, J.,
and O'Donovan, G.
(1976)
J. Gen. Microbiol.
92,
375-383[Abstract/Free Full Text]
|
| 8.
|
Isaac, J.,
and Holloway, B.
(1968)
J. Bacteriol.
96,
1732-1741[Abstract/Free Full Text]
|
| 9.
|
Abdelal, A. T.,
Bibb, W. F.,
and Nainan, O.
(1982)
J. Bacteriol.
151,
1411-1419[Abstract/Free Full Text]
|
| 10.
|
Abdelal, A.,
Bussey, L.,
and Vickers, L.
(1983)
Eur. J. Biochem.
129,
697-702[Medline]
[Order article via Infotrieve]
|
| 11.
|
Jones, M.,
Spector, L.,
and Lipmann, F.
(1955)
J. Am. Chem. Soc.
77,
819-820[CrossRef]
|
| 12.
|
Prescott, L. M.,
and Jones, M. E.
(1969)
Anal. Biochem.
32,
408-419[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Honzatko, R. B.,
Crawford, J. L.,
Monaco, H. L.,
Ladner, J. E.,
Ewards, B. F.,
Evans, D. R.,
Warren, S. G.,
Wiley, D. C.,
Ladner, R. C.,
and Lipscomb, W. N.
(1982)
J. Mol. Biol.
160,
219-263[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Ke, H. M.,
Honzatko, R. B.,
and Lipscomb, W. N.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4037-4040[Abstract/Free Full Text]
|
| 15.
|
Krause, K. L.,
Volz, K. W.,
and Lipscomb, W. N.
(1987)
J. Mol. Biol.
193,
527-553[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Lipscomb, W. N.
(1994)
Adv. Enzymol. Relat. Areas Mol. Biol.
68,
67-151[Medline]
[Order article via Infotrieve]
|
| 17.
|
Wild, J. R.,
and Wales, M. E.
(1990)
Annu. Rev. Microbiol.
44,
193-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Purcarea, C.,
Herve, G.,
Ladjimi, M. M.,
and Cunin, R.
(1997)
J. Bacteriol.
179,
4143-4157[Abstract/Free Full Text]
|
| 19.
|
Barbson, J. S.,
and Switzer, R. L.
(1975)
J. Biol. Chem.
250,
8664-8669[Abstract/Free Full Text]
|
| 20.
|
Lerner, C. G.,
and Switzer, R. L.
(1986)
J. Biol. Chem.
261,
11156-11165[Abstract/Free Full Text]
|
| 21.
|
Stevens, R. C.,
Reinisch, K. M.,
and Lipscomb, W. N.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
6087-6091[Abstract/Free Full Text]
|
| 22.
|
Adair, L. B.,
and Jones, M. E.
(1972)
J. Biol. Chem.
247,
2308-2315[Abstract/Free Full Text]
|
| 23.
|
Bergh, S. T.,
and Evans, D. R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9818-9822[Abstract/Free Full Text]
|
| 24.
|
Shepherdson, M.,
and McPhail, D.
(1993)
FEMS Microbiol. Lett.
114,
201-206[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Schurr, M. J.,
Vickrey, J. F.,
Kumar, A. P.,
Campbell, A. L.,
Cunin, R.,
Benjamin, R. C.,
Shanley, M. S.,
and O'Donovan, G. A.
(1995)
J. Bacteriol.
177,
1751-1759[Abstract/Free Full Text]
|
| 26.
|
Souciet, J.-L.,
Nagy, M.,
Legouar, M.,
Lacroute, F.,
and Potier, S.
(1989)
Gene (Amst.)
79,
59-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Wales, M. E.,
Madison, L. L.,
Glaser, S. S.,
and Wild, J. R.
(1999)
J. Mol. Biol.
294,
1387-1400[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Nowlan, S. F.,
and Kantrowitz, E. R.
(1985)
J. Biol. Chem.
260,
14712-14716[Abstract/Free Full Text]
|
| 29.
|
Maniatis, T.,
Fritsch, E. R.,
and Sambrook, I.
(1982)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 30.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 31.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Pastra-Landis, S. C.,
Foote, J.,
and Kantrowitz, E. R.
(1981)
Anal. Biochem.
118,
358-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Perbal, B.,
and Herve, G.
(1972)
J. Mol. Biol.
70,
511-529[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Webb, J.
(1963)
Enzyme and Metabolic Inhibitors
, Vol. 1
, pp. 507-510, Academic Press, New York
|
| 35.
|
Leger, D.,
and Herve, G.
(1988)
Biochemistry
27,
4293-4298[CrossRef]
|
| 36.
|
Perrin, D. D.,
and Sharma, V. S.
(1966)
Biochim. Biophys. Acta
127,
35-41[Medline]
[Order article via Infotrieve]
|
| 37.
|
Huff, J. P.,
Grant, B. J.,
Penning, C. A.,
and Sullivan, K. F.
(1990)
BioTechniques
9,
570-577
|
| 38.
|
Jancarik, J.,
and Kim, S.-H.
(1991)
J. Appl. Crystallogr.
24,
409-411[CrossRef]
|
| 39.
|
Weitzman, P. D. J.,
and Wilson, I. B.
(1966)
J. Biol. Chem.
241,
5481-5488[Abstract/Free Full Text]
|
| 40.
|
Dutta, O.,
and O'Donovan, G.
(1987)
J. Chromatogr.
385,
119-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Foote, J.,
and Schachman, H.
(1985)
J. Mol. Biol.
186,
175-184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Grayson, D. R.,
and Evans, D. R.
(1983)
J. Biol. Chem.
258,
4123-4129[Abstract/Free Full Text]
|
| 43.
|
Maley, J. A.,
and Davidson, J. N.
(1988)
Mol. Gen. Genet.
213,
278-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Issaly, I.,
Poiret, M.,
Tauc, P.,
Thiry, L.,
and Hervé, G.
(1982)
Biochemistry
21,
1612-1623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Vickrey, J. F.
(1993)
Isolation and Characterization of the Operon Containing Aspartate Transcarbamoylase and Dihydroorotase from Pseudomonas aeruginosa.Ph.D. thesis
, University of North Texas, Denton, TX
|
| 46.
|
Stalon, V.,
Ramos, F.,
Piérard, A.,
and Wiame, J. M.
(1972)
Eur. J. Biochem.
29,
25-35[Medline]
[Order article via Infotrieve]
|
| 47.
|
Mercenier, A.,
Simon, J. P.,
Vander Wauven, C.,
Haas, D.,
and Stalon, V.
(1980)
J. Bacteriol.
44,
159-163
|
| 48.
|
Shoesmith, J. G.,
and Sherris, J. C.
(1960)
J. Gen. Microbiol.
22,
10-24[Abstract/Free Full Text]
|
| 49.
|
Bauer, H.,
Luethi, E.,
Stalon, V.,
Mercenier, A.,
and Haas, D.
(1989)
Eur. J. Biochem
179,
53-60[Medline]
[Order article via Infotrieve]
|
| 50.
|
Haas, D.,
Holloway, B. W.,
Schambock, A.,
and Leisinger, T.
(1977)
Mol. Gen. Genet.
154,
7-22[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Ahuja, C. Purcarea, R. Ebert, S. Sadecki, H. I. Guy, and D. R. Evans
Aquifex aeolicus Dihydroorotase: ASSOCIATION WITH ASPARTATE TRANSCARBAMOYLASE SWITCHES ON CATALYTIC ACTIVITY
J. Biol. Chem.,
December 17, 2004;
279(51):
53136 - 53144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Barbe, D. Vallenet, N. Fonknechten, A. Kreimeyer, S. Oztas, L. Labarre, S. Cruveiller, C. Robert, S. Duprat, P. Wincker, et al.
Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium
Nucleic Acids Res.,
October 28, 2004;
32(19):
5766 - 5779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Purcarea, A. Ahuja, T. Lu, L. Kovari, H. I. Guy, and D. R. Evans
Aquifex aeolicus Aspartate Transcarbamoylase, an Enzyme Specialized for the Efficient Utilization of Unstable Carbamoyl Phosphate at Elevated Temperature
J. Biol. Chem.,
December 26, 2003;
278(52):
52924 - 52934.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|